<DOC>
	<DOCNO>NCT00161551</DOCNO>
	<brief_summary>The purpose study determine incidence atrial fibrillation heart failure patient pacemaker therapy different pace mode ( AAI , DDD , novel algorithm minimize ventricular pacing ) .</brief_summary>
	<brief_title>Mode Evaluation Sick Sinus Syndrome Trial ( MODEST )</brief_title>
	<detailed_description>Background : Dual-chamber pacemaker therapy become mainstay treat symptomatic sick sinus syndrome ( SSS ) . This approach aim result physiologic conduction pattern , protect atrioventricular conduction anomaly . Smaller study subgroup analysis large trial suggest ventricular stimulation associate treatment adverse effect , especially increased incidence atrial fibrillation heart failure . Methods : In MODEST , study patient sick sinus syndrome indication pace therapy , atrial pacing ( AAI ) compare dual-chamber pacing ( DDD ) combine novel algorithm develop low number ventricularly pace beat . The study aim assess impact ventricular pacing development atrial arrhythmias test hypothesis DDD pace use algorithm associate high rate atrial arrhythmia atrial pacing . Included patient SSS high degree AV node disease except patient first-degree AV block ≤300ms . Patients follow stratified Wenckebach point ( ≥ 120 bpm versus &lt; 120 bpm ) . Conclusion : MODEST large , prospective , randomize , multicenter trial aim compare novel type dual-chamber pace approach ( include algorithm design low number ventricularly pace beat ) pure atrial pacing , assess impact incidence atrial arrhythmia patient sick sinus syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Symptomatic sinus bradycardia , Sinusarrest Symptomatic SA block BradycardiaTachycardiaSyndrome Binodal diseases 1st degree AV Block 2nd degree AV block 3rd degree AV block Total right bundle branch block Indication biventricular stimulation Inter atrial conduction delay ( Pwave &gt; 150MS ) Permanent therapy refractory Atrial Fibrillation Heart Failure acc . NYHA III IV Myocardial Infarction le 6 month pacemaker implant Hypertrophic obstructive cardiomyopathy Symptomatic hypo hyperthyreosis Cardiogenic shock Pregnancy Lactation period Unstable angina pectoris Poorly control Diabetes mellitus Neuromuscular diseases Patients 18 year age Patients involved study Reduced expectancy life due diseases Patients attend followup visit regularly</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Cardiac Pacing , artificial</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Pacemaker lead</keyword>
	<keyword>Pacing Mode</keyword>
</DOC>